This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   Dec. 23, 2013


Better Results Can Change the World


Watch the latest video application note from Waters: The Direct Analysis of Opioids and Metabolites from Whole Blood...

 



Most states letting down guard against infectious disease
Medscape Medical News
The United States has let its guard down against infectious disease, particularly at the state level, where 34 states have a score of 5 or lower on 10 indicators of public health protection, according to a new study published online by Trust for America's Health and the Robert Wood Johnson Foundation.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




ACC/AHA publish new guideline for management of blood cholesterol
American Heart Association
The American College of Cardiology and the American Heart Association released a new clinical practice guideline for the treatment of blood cholesterol in people at high risk for cardiovascular diseases caused by atherosclerosis, or hardening and narrowing of the arteries, that can lead to heart attack, stroke or death. The guideline identifies four major groups of patients for whom cholesterol-lowering HMG-CoA reductase inhibitors, or statins, have the greatest chance of preventing stroke and heart attacks.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


A new gene target for fighting cancer
MIT Technology Review
About half of all cancer patients have a mutation in a gene called p53, which codes for a tumor-suppressing protein that controls cell division. That mutation allows tumors to continue growing even after chemotherapy damages their DNA. A new study from MIT biologists has found that tumor cells with mutated p53 can be made much more vulnerable to chemotherapy by blocking another gene, called MK2. In a study of mice, tumors lacking both p53 and MK2 shrank dramatically when treated with the drug Cisplatin, while tumors with functional MK2 kept growing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


A blood test that predicts suicide?
By Dorothy L. Tengler
Suicide is the 10th-leading cause of death for Americans. In 2010, someone in the United States died by suicide every 13.7 minutes. Alexander Niculescu, a psychiatrist at Indiana University in Indianapolis, has been looking for biological signs of suicide risk in an effort to prevent these tragedies. Because of the brain's complexity and inaccessibility, he has focused on molecular signs, such as biomarkers. Niculescu and colleagues recently identified six such biomarkers in the blood that may identify people at risk of committing suicide.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
 


'Nanobiopsy' allows scientists to operate on living cells
Imperial College London
Scientists have developed a device that can take a "biopsy" of a living cell, sampling minute volumes of its contents without killing it. Much research on molecular biology is carried out on populations of cells, giving an average result that ignores the fact that every cell is different. Techniques for studying single cells usually destroy them, making it impossible to look at changes over time.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword CELLS




More evidence that blood transfusions raise thrombosis risk in ACS patients
Medscape Medical News
Many patients hospitalized with acute coronary syndromes receive blood or blood products due to bleeding complications or in response to anemia, yet there is also evidence that transfusions may be an independent risk factor for ischemic events, observe Dr Johanne Silvain and colleagues in a study published online in the Journal of the American College of Cardiology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
If you only run QC once a day, we recommend this simple exercise.

Download our Patient Risk Management White Paper to read how a patient risk approach to QC means planning your QC based on the type or method of the test and its impact on patient outcomes when a failure is detected. As the world's leader in clinical laboratory QC, we're creating the groundwork to help you make the transition to patient-focused QC.

Call us today at 1-800-224-6723 to learn more or visit www.qcnet.com/
patientriskASCLS
Trust in Cleveland Clinic Laboratories

Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
New Affordable LED Lighting System

Bridging the gap between costly color-specific LED lighting and lower-cost conventional fluorescent lighting, Percival Scientific, Inc. has introduced the LED-Elite Series. These research chambers feature a multicolor LED lamp providing the correct spectral quality at the correct irradiance with exceptional environmental control every time. A webinar explaining the features and benefits is available at www.percival-scientific.com


Cancer and immune cells merge
The Scientist
Macrophages are usually the body's protectors, engulfing pathogens and cleaning up dead cells and debris. But in some cases, cancer cells fuse with these immune cells to possibly become even more harmful, according to a poster presented recently at the American Society for Cell Biology Annual Meeting in New Orleans. The researchers demonstrated that macrophages and mouse colon cancer cells spontaneously fuse when cultured together and noted altered growth in the hybrid cells compared to ordinary cancer cells, prompting speculation that hybridization could spur cancer progression.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    What workers want in a job (By Mel Kleiman)
Study: Washing hands in hot water wastes energy (National Geographic)
FDA hopes to curb antibiotic use on farms (CNN)
3 heart cases, deaths tied to Lyme disease (The Boston Globe)

Don't be left behind. Click here to see what else you missed.




North Texas hospital performing groundbreaking breast cancer research
KTVT-TV
VideoBrief Groundbreaking research underway right now in North Texas is helping breast cancer patients avoid mastectomies and make treatment decisions based on fact, not fear. For the past two years, Dr. Peter Beitsch has been leading a major clinical study conducting genetic analysis of breast cancer tumors. The information is then used to design a patient specific treatment plan.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
MOST POPULAR ARTICLE
TRENDING ARTICLE
Exercise can ease pain from breast cancer drugs
USA Today
Supervised exercise may help relieve treatment-related pain among breast cancer patients, a new study finds. The study focused on hormonal therapies called aromatase inhibitors, which certain post-menopausal breast cancer patients take for up to five years after surgery.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Why do tumors become resistant to chemotherapy?
Bellvitge Biomedical Research Institute via Science Codex
A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. What happened?

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Hospitals try yogurt to prevent infections in patients
The Wall Street Journal
Holy Redeemer Hospital in Meadowbrook, Pa., was able to drive down cases of hospital infections after adding a new weapon to its arsenal: probiotics, the small organisms that help maintain the natural balance of bacteria in the intestines.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


Camels harbor MERS virus
MedPage Today
A farm in Qatar might hold the clues that link the emerging Middle East respiratory syndrome to camels. For the first time, the virus has been isolated from a non-human species — camels on a small farm that is also linked to two human cases, according to Marion Koopmans, DVM, Ph.D., of Erasmus Medical Center in Rotterdam, and colleagues.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

Dec. 17, 2013
Dec 11, 2013 blast
Dec. 10, 2013
Dec. 3, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063